Hepion Pharmaceuticals, Inc.
HEPA
$0.06
-$0.03-35.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 76.49% | 81.86% | 37.25% | 59.62% | 52.19% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | 67.34% | -- |
| Total Other Non-Cash Items | -99.00% | -84.40% | 223.97% | 409.24% | 300.56% |
| Change in Net Operating Assets | -25.50% | 548.92% | 118.38% | 105.31% | 127.85% |
| Cash from Operations | 74.14% | 89.98% | 82.04% | 84.30% | 82.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 77.98% | 77.98% | 77.98% | -- |
| Cash from Investing | 100.00% | 77.98% | 77.98% | 77.99% | -31,930.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 87.83% | 81.86% | -- | -- | -- |
| Issuance of Common Stock | -93.91% | -97.83% | 106.91% | 1.76% | 81.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.26% | 100.00% | -- | -- | -- |
| Cash from Financing | -96.10% | -103.54% | 10.93% | -43.63% | 20.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 83.48% | 108.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -260.09% | 76.71% | 109.89% | 104.63% | 102.85% |